Xue Zhou Selected Research

Spinal Cord Injuries (Spinal Cord Injury)

7/2017	Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression.
4/2016	Knockdown of α-synuclein in cerebral cortex improves neural behavior associated with apoptotic inhibition and neurotrophin expression in spinal cord transected rats.
6/2007	Temporal changes in the expression of some neurotrophins in spinal cord transected adult rats.
1/2007	[Changes in number of EGF positive neurons in ventral horn and contralateral cortex motor area of rhesus after hemisection spinal cord injury].
3/2005	[Changes in expression of SP in spinal lamina II following hemisected spinal cord injury in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue Zhou Research Topics

Disease

45	Neoplasms (Cancer) 04/2024 - 11/2009
20	Infections 01/2024 - 08/2014
11	Inflammation (Inflammations) 02/2024 - 10/2018
11	Carcinogenesis 01/2022 - 09/2008
9	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 11/2011
6	Body Weight (Weight, Body) 02/2024 - 12/2017
6	COVID-19 01/2024 - 01/2020
6	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2008
6	Pain (Aches) 01/2023 - 01/2010
5	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2020
5	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2009
5	Hyperglycemia 07/2020 - 01/2012
5	Spinal Cord Injuries (Spinal Cord Injury) 07/2017 - 03/2005
5	Carcinoma (Carcinomatosis) 05/2013 - 09/2008
4	Chronic Hepatitis B 01/2024 - 12/2018
4	Neuralgia (Stump Neuralgia) 01/2023 - 05/2010
4	Atrial Fibrillation 01/2022 - 01/2013
4	Fibrosis (Cirrhosis) 12/2021 - 01/2013
4	Hyperalgesia 01/2021 - 10/2016
4	Pre-Eclampsia (Preeclampsia) 01/2019 - 05/2010
4	Hypoxia (Hypoxemia) 12/2015 - 11/2008
3	Hyperlipidemias (Hyperlipidemia) 02/2024 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 12/2023 - 06/2020
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2022
3	Dysbiosis 05/2023 - 06/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 03/2019
3	Adenocarcinoma of Lung 02/2023 - 01/2022
3	Insulin Resistance 01/2023 - 08/2016
3	Cognitive Dysfunction 01/2023 - 05/2021
3	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 01/2021
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 04/2018
3	Liver Neoplasms (Liver Cancer) 12/2021 - 06/2017
3	Necrosis 12/2021 - 11/2011
3	Diarrhea 01/2017 - 06/2015
2	Squamous Cell Carcinoma of Head and Neck 04/2024 - 01/2023
2	Obesity 02/2024 - 05/2019
2	Chronic Disease (Chronic Diseases) 01/2024 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 12/2021
2	Reperfusion Injury 12/2023 - 12/2015
2	Emergence Delirium 12/2023 - 08/2023
2	Schistosomiasis japonica 09/2023 - 08/2022
2	Atherosclerosis 08/2023 - 01/2022
2	Hypertension (High Blood Pressure) 01/2023 - 01/2020
2	Leukemia 01/2023 - 12/2020
2	Autism Spectrum Disorder 01/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 02/2023 - 05/2010
14	Biomarkers (Surrogate Marker)IBA 06/2024 - 01/2020
9	MicroRNAs (MicroRNA)IBA 06/2021 - 08/2014
8	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
7	Messenger RNA (mRNA)IBA 02/2023 - 05/2010
6	CadmiumIBA 09/2021 - 01/2015
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 01/2013
5	RNA (Ribonucleic Acid)IBA 06/2024 - 12/2021
5	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2015
5	CytokinesIBA 06/2022 - 01/2020
4	LipidsIBA 02/2023 - 01/2018
4	SirtuinsIBA 01/2023 - 09/2017
4	VaccinesIBA 01/2023 - 12/2002
4	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2021
4	PolymersIBA 10/2021 - 03/2014
4	Circular RNAIBA 09/2021 - 01/2019
4	Insulin (Novolin)FDA Link 01/2021 - 01/2018
4	ArsenicIBA 01/2018 - 04/2009
3	Therapeutic UsesIBA 02/2024 - 01/2010
3	EnzymesIBA 10/2023 - 06/2022
3	Epidermal Growth Factor (EGF)IBA 10/2023 - 01/2007
3	Hormones (Hormone)IBA 09/2023 - 01/2020
3	LigandsIBA 08/2023 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 01/2021
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2023 - 10/2018
3	AntigensIBA 01/2022 - 02/2015
3	hydroxide ionIBA 01/2022 - 06/2017
3	CollagenIBA 01/2022 - 05/2015
3	Vitamin D FDA LinkGeneric 01/2022 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2018
3	SynucleinsIBA 01/2021 - 04/2016
3	Blood Glucose (Blood Sugar)IBA 07/2020 - 01/2012
3	methylallyl trisulfide (MATS)IBA 06/2020 - 05/2013
3	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 10/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 04/2024 - 04/2016
2	IronIBA 03/2024 - 11/2013
2	TeaIBA 02/2024 - 01/2018
2	Sterol Regulatory Element Binding Protein 1IBA 02/2024 - 08/2020
2	COVID-19 VaccinesIBA 01/2024 - 01/2023
2	linvencorvirIBA 01/2024 - 01/2023
2	CalciumIBA 12/2023 - 01/2023
2	AcidsIBA 12/2023 - 01/2023
2	Atorvastatin (Lipitor)FDA Link 02/2023 - 01/2023
2	Antihypertensive Agents (Antihypertensives)IBA 02/2023 - 01/2020
2	Losartan (Cozaar)FDA LinkGeneric 02/2023 - 01/2023

Therapy/Procedure

30	Therapeutics 02/2024 - 01/2013
6	Immunotherapy 01/2023 - 01/2020
5	Drug Therapy (Chemotherapy) 10/2023 - 01/2015
4	Radiotherapy 01/2023 - 01/2021
3	Aftercare (After-Treatment) 09/2023 - 01/2010
3	Acupuncture Therapy 12/2022 - 04/2016
2	Decompression 01/2024 - 01/2023
2	Anesthesia 05/2023 - 10/2015